Therapeutic aspects of disseminated intravascular coagulation.
D000743:Anemia, Hemolytic / Q000097:blood; D000818:Animals; D001775:Blood Circulation; D001778:Blood Coagulation Disorders / Q000188:drug therapy / Q000209:etiology / Q000628:therapy*; D001779:Blood Coagulation Factors / Q000378:metabolism; D001792:Blood Platelets / Q000187:drug effects; D001808:Blood Vessels / Q000187:drug effects; D004285:Dogs; D005342:Fibrinolysis; D006474:Hemorrhagic Disorders / Q000209:etiology; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D007938:Leukemia / Q000097:blood; D008103:Liver Cirrhosis / Q000097:blood; D009203:Myocardial Infarction / Q000188:drug therapy; D009638:Norepinephrine / Q000494:pharmacology; D010101:Oxygen Consumption; D010195:Pancreatitis / Q000097:blood; D011817:Rabbits; D018805:Sepsis / Q000150:complications; D012771:Shock, Hemorrhagic / Q000097:blood; D012772:Shock, Septic / Q000378:metabolism; D012774:Shock, Traumatic / Q000097:blood; D013300:Streptokinase / Q000627:therapeutic use
D001779:Blood Coagulation Factors; D006493:Heparin; D013300:Streptokinase; D009638:Norepinephrine